Mesa Laboratories (MLAB) Stock Price, News & Analysis

Company Overview

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Key Stats

• Today's Range: $111.39 to $113.61
• 50-Day Range: $105.24 to $150.20
• 52-Week Range: $83.68 to $155.12
• Volume: 40,279 shs
• Average Volume: 39,136 shs
• Market Capitalization: $608.66 million
• P/E Ratio: N/A
• Dividend Yield: 0.57%
• Price Target: $140.00
• Consensus Rating: Hold

Mesa Laboratories Stock Analysis - MarketRank™

Mesa Laboratories scored higher than 45% of companies evaluated by MarketBeat, and ranked 342nd out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.0 / 5
• Analyst Rating: Hold

Consensus Rating

Mesa Laboratories has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Mesa Laboratories has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 9.00%

Earnings Growth

Earnings for Mesa Laboratories are expected to grow by 9.00% in the coming year, from $8.00 to $8.72 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Mesa Laboratories is -2.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Mesa Laboratories is -2.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Mesa Laboratories has a P/B Ratio of 3.92. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.59% of the float of Mesa Laboratories has been sold short.

Short Interest Ratio / Days to Cover

Mesa Laboratories has a short interest ratio ("days to cover") of 4.5.

Change versus previous month

Short interest in Mesa Laboratories has recently decreased by 0.85%, indicating that investor sentiment is improving.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Mesa Laboratories has a dividend yield of 0.55%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Mesa Laboratories does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Mesa Laboratories will have a dividend payout ratio of 7.34% next year. This indicates that Mesa Laboratories will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

3.59% of the float of Mesa Laboratories has been sold short.

Short Interest Ratio / Days to Cover

Mesa Laboratories has a short interest ratio ("days to cover") of 4.5.

Change versus previous month

Short interest in Mesa Laboratories has recently decreased by 0.85%, indicating that investor sentiment is improving.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: 1.71

News Sentiment

Mesa Laboratories has a news sentiment score of 1.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Mesa Laboratories this week, compared to 2 articles on an average week.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Mesa Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,602,110.00 in company stock.

Percentage Held by Insiders

Only 4.40% of the stock of Mesa Laboratories is held by insiders.

Percentage Held by Institutions

90.60% of the stock of Mesa Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

MLAB Stock Analysis - Frequently Asked Questions

How have MLAB shares performed this year?

Mesa Laboratories' stock was trading at $131.87 at the start of the year. Since then, MLAB shares have decreased by 15.1% and is now trading at $112.01.
View the best growth stocks for 2025 here.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) posted its quarterly earnings results on Tuesday, February, 4th. The medical instruments supplier reported $2.07 EPS for the quarter, beating the consensus estimate of $1.41 by $0.66. Mesa Laboratories had a positive trailing twelve-month return on equity of 30.23% and a negative net margin of 104.92%.

Who are Mesa Laboratories' major shareholders?

Mesa Laboratories' top institutional investors include Conestoga Capital Advisors LLC (10.51%), GAMMA Investing LLC (0.33%), Rhumbline Advisers (0.25%) and Kings Path Partners LLC (0.08%). Insiders that own company stock include John Bradley Schmieder, Gary M Owens, Evan Guillemin, John James Sullivan, John Sakys, Shannon Hall and Brian David Archbold.
View institutional ownership trends.

How do I buy shares of Mesa Laboratories?

Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Mesa Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Mesa Laboratories investors own include American Water Works (AWK), Waste Connections (WCN), AUO (AUOTY), DiamondRock Hospitality (DRH), The RMR Group (RMR), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

• Last Earnings: 2/04/2025
• Record date for 3/17 Dividend: 2/28/2025
• Ex-Dividend for 3/17 Dividend: 2/28/2025
• Dividend Payable: 3/17/2025
• Today: 4/20/2025
• Record date for 6/16 Dividend: 5/30/2025
• Ex-Dividend for 6/16 Dividend: 5/30/2025
• Next Earnings (Estimated): 6/04/2025
• Dividend Payable: 6/16/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Process control instruments
• Sub-Industry: Electronic Equipment & Instruments
• Current Symbol: NASDAQ:MLAB
• CIK: 724004
• Web: www.mesalabs.com
• Phone: (303) 987-8000
• Fax: 303-987-8989
• Employees: 680
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $140.00
• High Stock Price Target: $160.00
• Low Stock Price Target: $120.00
• Potential Upside/Downside: +25.0%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($46.26)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 14.00
• P/E Growth: N/A
• Net Income: $-254,250,000.00
• Net Margins: -104.92%
• Pretax Margin: -113.50%
• Return on Equity: 30.23%
• Return on Assets: 10.43%

Debt

• Debt-to-Equity Ratio: 0.61
• Current Ratio: 0.71
• Quick Ratio: 0.53

Sales & Book Value

• Annual Sales: $237.75 million
• Price / Sales: 2.56
• Cash Flow: $44.63 per share
• Price / Cash Flow: 2.51
• Book Value: $28.57 per share
• Price / Book: 3.92

Miscellaneous

• Outstanding Shares: 5,434,000
• Free Float: 5,195,000
• Market Cap: $608.66 million
• Optionable: Not Optionable
• Beta: 0.92